The DeoR-type transcriptional regulator SugR acts as a repressor for genes encoding the phosphoenolpyruvate:sugar phosphotransferase system (PTS) in Corynebacterium glutamicum.

The DeoR-type transcriptional regulator SugR acts as a repressor for genes encoding the phosphoenolpyruvate:sugar phosphotransferase system (PTS) in Corynebacterium glutamicum. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

The DeoR-type transcriptional regulator SugR acts as a repressor for genes encoding the phosphoenolpyruvate:sugar phosphotransferase system (PTS) in Corynebacterium glutamicum. Abstract Text:

Lars Gaigalat,Jan-Philip Schlüter,Michelle Hartmann,Sascha Mormann,Andreas Tauch,Alfred Pühler,Jörn Kalinowski,Lars Gaigalat,Jan-Philip ,Michelle Hartmann,Sascha Mormann,Andreas Tauch,Alfred , Kalinowski,

BACKGROUND: The major uptake system responsible for the transport of fructose, glucose, and sucrose in Corynebacterium glutamicum ATCC 13032 is the phosphoenolpyruvate:sugar phosphotransferase system (PTS). The genes encoding PTS components, namely ptsI, ptsH, and ptsF belong to the fructose-PTS gene cluster, whereas ptsG and ptsS are located in two separate regions of the C. glutamicum genome. Due to the localization within and adjacent to the fructose-PTS gene cluster, two genes coding for DeoR-type transcriptional regulators, cg2118 and sugR, are putative candidates involved in the transcriptional regulation of the fructose-PTS cluster genes. RESULTS: Four transcripts of the extended fructose-PTS gene cluster that comprise the genes sugR-cg2116, ptsI, cg2118-fruK-ptsF, and ptsH, respectively, were characterized. In addition, it was shown that transcription of the fructose-PTS gene cluster is enhanced during growth on glucose or fructose when compared to acetate. Subsequently, the two genes sugR and cg2118 encoding for DeoR-type regulators were mutated and PTS gene transcription was found to be strongly enhanced in the presence of acetate only in the sugR deletion mutant. The SugR regulon was further characterized by microarray hybridizations using the sugR mutant and its parental strain, revealing that also the PTS genes ptsG and ptsS belong to this regulon. Binding of purified SugR repressor protein to a 21 bp sequence identified the SugR binding site as an AC-rich motif. The two experimentally identified SugR binding sites in the fructose-PTS gene cluster are located within or downstream of the mapped promoters, typical for transcriptional repressors. Effector studies using electrophoretic mobility shift assays (EMSA) revealed the fructose PTS-specific metabolite fructose-1-phosphate (F-1-P) as a highly efficient, negative effector of the SugR repressor, acting in the micromolar range. Beside F-1-P, other sugar-phosphates like fructose-1,6-bisphosphate (F-1,6-P) and glucose-6-phosphate (G-6-P) also negatively affect SugR-binding, but in millimolar concentrations. CONCLUSION: In C. glutamicum ATCC 13032 the DeoR-type regulator SugR acts as a pleiotropic transcriptional repressor of all described PTS genes. Thus, in contrast to most DeoR-type repressors described, SugR is able to act also on the transcription of the distantly located genes ptsG and ptsS of C. glutamicum. Transcriptional repression of the fructose-PTS gene cluster is observed during growth on acetate and transcription is derepressed in the presence of the PTS sugars glucose and fructose. This derepression of the fructose-PTS gene cluster is mainly modulated by the negative effector F-1-P, but reduced sensitivity to the other effectors, F-1,6-P or G-6-P might cause differential transcriptional regulation of genes of the general part of the PTS (ptsI, ptsH) and associated genes encoding sugar-specific functions (ptsF, ptsG, ptsS).

The DeoR-type transcriptional regulator SugR acts as a repressor for genes encoding the phosphoenolpyruvate:sugar phosphotransferase system (PTS) in Corynebacterium glutamicum. Publishing Authors By Initials

L Gaigalat,JP Schlüter,M Hartmann,S Mormann,A Tauch,A Pühler,J Kalinowski,L Gaigalat,JP ,M Hartmann,S Mormann,A Tauch,A ,J Kalinowski,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

The DeoR-type transcriptional regulator SugR acts as a repressor for genes encoding the phosphoenolpyruvate:sugar phosphotransferase system (PTS) in Corynebacterium glutamicum. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: BMC molecular biology

VOLUME: 8

Page Numbers: 104

Journal Abbreviation: BMC Mol. Biol.

ISSN: 1471-2199

DAY: 15

MONTH: 11

YEAR: 2007

The DeoR-type transcriptional regulator SugR acts as a repressor for genes encoding the phosphoenolpyruvate:sugar phosphotransferase system (PTS) in Corynebacterium glutamicum. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 100966983

The DeoR-type transcriptional regulator SugR acts as a repressor for genes encoding the phosphoenolpyruvate:sugar phosphotransferase system (PTS) in Corynebacterium glutamicum. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: The DeoR-type transcriptional regulator SugR acts as a repressor for genes encoding the phosphoenolpyruvate:sugar phosphotransferase system (PTS) in Corynebacterium glutamicum. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for The DeoR-type transcriptional regulator SugR acts as a repressor for genes encoding the phosphoenolpyruvate:sugar phosphotransferase system (PTS) in Corynebacterium glutamicum.

AFFILIATION: Institut für Genomforschung, Universität Bielefeld, D-33594 Bielefeld, Germany. lars.gaigalat@Genetik.Uni-Bielefeld.DE

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: BMC Mol Biol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

The DeoR-type transcriptional regulator SugR acts as a repressor for genes encoding the phosphoenolpyruvate:sugar phosphotransferase system PTS in Corynebacterium glutamicum Related Publications

• "Eye"Dentifying vision impairment in the geriatric patient.
• Changes in epidemiology of viral hepatitis in Poland at the end of the 20th century.
• Changes in health status of the Polish population after 1990.
• Chronic sciatic pain in a young woman with sclerosis of the lliac bone.
• Classification of heterogeneous electron microscopic projections into homogeneous subsets.
• Cyclization of phenoxyacetic acid and some chlorophenoxyacetic acids.
• Dental age in Central Poland.
• Epidemiological situation of tuberculosis in Poland at the end of the 20th century.
• Excess male mortality at the productive age in Poland at the end of the 20th century.
• Foodborne infections and intoxications in the Lublin voivodeship in the years 1980-2000 in comparison with their prevalence in the Polish population.
• Investigation of central carbon metabolism and the 2-methylcitrate cycle in Corynebacterium glutamicum by metabolic profiling using gas chromatography-mass spectrometry.
• Measurement of composite shrinkage using a fibre optic Bragg grating sensor.
• Patterns of relatedness and parentage in an asocial, polyandrous striped hyena population.
• Prevalence of infections of the Salmonella strains in the Lublin voivodeship and in Poland in the years 1980-2000.
• Somnambulism induced by quetiapine: two case reports and a review of the literature.
• The DeoR-type transcriptional regulator SugR acts as a repressor for genes encoding the phosphoenolpyruvate:sugar phosphotransferase system (PTS) in Corynebacterium glutamicum.
• The analysis of the causative factors and types of traumas in disabled inhabitants of rural areas in Poland.
• The influence of prophylactic vaccination on epidemic situation of infectious diseases illustrated by the epidemiology of measles in Poland in the years 1968-1998.
• Two cases of somnambulism induced by quetiapine.
• [Békésy audiometry in post-traumatic conditions of the skull]
• [Electronystagmographic studies of positional nystagmus after cranial injuries]
• [Examination of smell and taste in patients with closed skull trauma]
• [On the syndrome of obsession with parasitic dermatosis]
• [Results of therapy with the preparation Bayer E 39.]